中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
JZL184抑制剂 |
4-nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate |
1101854-58-3 |
C27H24N2O9 |
|
JZL-195抑制剂 |
(4-Nitrophenyl) 4-[(3-phenoxyphenyl)methyl]piperazine-1-carboxylate |
1210004-12-8 |
C24H23N3O5 |
|
JWH073丁酸代谢物 |
4-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]butanoic acid |
1307803-52-6 |
C23H19NO3 |
|
JWH0187-羟基吲哚代谢物 |
(7-hydroxy-1-pentyl-1H-indol-3-yl)(naphthalen-1-yl)methanone |
1307803-45-7 |
C24H23NO2 |
|
JWH-398((4-氯萘-1-基)(1-pentylindol-3-基)甲酮)标准品 |
JWH-398 |
1292765-18-4 |
C24H22ClNO |
|
JWH-1225-羟基戊基 |
JWH-122 N-(5-hydroxypentyl)metabolite |
1379604-68-8 |
C25H25NO2 |
|
JWH-0732-羟基吲代谢物 |
JWH 073 2-hydroxyindole metabolite |
1427325-54-9 |
C23H21NO2 |
|
JWH-072-N-羧酸 |
JWH 018 N-propanoic acid metabolite |
1451369-32-6 |
C22H17NO3 |
|
JWH-018omega-羟基戊基 |
JWH-018 N-(5-Hydroxypentyl) |
335161-21-2 |
C24H23NO2 |
|
JWH-018N-戊基-5-羧酸 |
5-[3-(naphthalene-1-carbonyl)-1H-indol-1-yl]pentanoic acid |
1254475-87-0 |
C24H21NO3 |
|
JWH-0184-羟基戊基代谢物标准品 |
(1-(4-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone |
1320363-47-0 |
C24H23NO2 |
|
JWH 251 4-甲基苯基异构体 |
2-(4-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone |
864445-41-0 |
C22H25NO |
|
JWH 203 3-氯异构体 |
JWH 237 |
864445-56-7 |
C21H22ClNO |
|
JPM 565 乙基酯 |
[125I]-JPM-OEt |
262381-84-0 |
C20H28N2O6 |
|
JP1302二盐酸盐 |
MMV006172 |
80259-18-3 |
C24H24N4 |
|
JNK抑制剂II,阴性对照 |
JNK Inhibitor II, Negative Control |
54642-23-8 |
C15H10N2O |
|
JNK抑制剂(BI-78D3) |
4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one |
883065-90-5 |
C13H9N5O5S2 |
|
JNJ-40346527游离态 |
4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide |
1142363-52-7 |
C27H35N5O2 |
|
JNJ 5207787; 反式-N-(1-乙酰基-2,3-二氢-1H-吲哚-6-基)-3-(3-氰基苯基)-N-[1-(2-环戊基乙基)哌啶-4-基]丙烯酰胺 |
trans-N-(1-acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyanophenyl)-N-[1-(2-cyclopentylethyl)piperidin-4-yl]acrylamide |
683746-68-1 |
C32H38N4O2 |
|
JNJ 3026582; 4-(4-氟苯基)-2-(4-羟基-1-丁炔)-1-(3-苯基丙基)-5-(4-吡啶基)咪唑 |
RWJ67657 |
215303-72-3 |
C27H24FN3O |
|
JDTic;(3R)-1,2,3,4-四氢-7-羟基-N-[(1S)-1-[[(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基]甲基]-2-甲基丙基]-3-异喹啉甲酰胺 |
(3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide |
361444-66-8 |
C28H39N3O3 |
|
JAK激酶抑制剂 |
Peficitinib hydrobromide |
1353219-05-2 |
C18H23BrN4O2 |
|
JAK2抑制剂V,Z3 |
NSC 42834 |
195371-52-9 |
C23H24N2O |
|
I型P21激活激酶(PAK)抑制剂(FRAX597) |
FRAX597 |
1286739-19-2 |
C29H28ClN7OS |
|
I咪达那新杂质(N-(3氨基甲酰基3,3-DIPHENYLPROPYL)-OXAMIC酸) |
N-(3-carbamoyl-3,3-diphenylpropyl)oxamic acid |
503598-07-0 |
C18H18N2O4 |
|
Ivacaftor苯磺酸盐 |
N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide.besylate |
1134822-09-5 |
C6H6O3S*C24H28N2O3 |
|
Isoboonein; (4aR,6S,7R,7aS)-六氢-6-羟基-7-甲基环戊并[c]吡喃-3(1H)-酮 |
isoboonein |
99946-04-0 |
C9H14O3 |
|
Isoboonein acetate; (4aR,6S,7R,7aS)-6-(乙酰氧基)六氢-7-甲基环戊并[c]吡喃-3(1H)-酮 |
Isoboonein acetate |
99891-77-7 |
C11H16O4 |
|
Isobonducellin; (3Z)-2,3-二氢-7-羟基-3-[(4-甲氧基苯基)亚甲基]-4H-1-苯并吡喃-4-酮 |
(Z)-7-hydroxy-3-(4'-methoxybenzylidene)chroman-4-one |
610778-85-3 |
C17H14O4 |
|
Ipragliflozin; (1S)-1,5-脱水-1-C-[3-[(1-苯并噻吩-2-基)甲基]-4-氟苯基]-D-葡糖醇 |
ipragliflozin |
761423-87-4 |
C21H21FO5S |
|
Im-bzl-L-组氨酸甲酯 |
N'-benzyl-L-histidine methyl ester |
19817-75-5 |
C14H17N3O2 |
|
Idasanutlin(4-((2R,3S,4R,5S)-3-(3-氯-2-氟苯基)-4-(4-氯-2-氟苯基)-4-氰基-5-新戊基吡咯烷-2-甲酰胺)-3-甲氧基苯甲酸;) |
idasanutlin |
1229705-06-9 |
C31H29Cl2F2N3O4 |
|
IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 |
N-(6-Methyl-2-benzothiazolyl)-2-[(3,4,6,7-tetrahydro-4-oxo-3-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-acetamide |
686770-61-6 |
C22H18N4O2S3 |
|
IU1抑制剂 |
1-[1-(4-fluorophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]-2-(pyrrolidin-1-yl)ethan-1-one |
314245-33-5 |
C18H21FN2O |
|
ITI214自由基 |
(6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one |
1160521-50-5 |
C29H26FN7O |
|
IS(+)-3-溴樟脑-10-磺酸 |
((1S,3S,4S)-3-bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid hydrate |
206860-46-0 |
C10H17BrO5S |
|
IRTK激活剂,负控制 |
3,6-dihydroxy-2-(4-methoxyphenyl)-5-phenyl-1,4-benzoquinone |
6172-50-5 |
C19H14O5 |
|
IRE1抑制剂(STF-083010) |
N-[(2-hydroxy-1-naphthalenyl)methylene]-2-thiophenesulfonamide |
307543-71-1 |
C15H11NO3S2 |
|
IRAK抑制剂5;3-硝基-N-[1-(3-羟基丙基)-5-(2,2-二甲基丙酰基氧基)-1H-苯并咪唑-2-基]苯甲酰胺 |
1-(3-Hydroxypropyl)-2-[(3-Nitrobenzoyl)amino]-1h-Benzimidazol-5-Yl Pivalate |
509093-60-1 |
C22H24N4O6 |
|
IRAK-1-4 抑制剂 I |
IRAK-1/4 Inhibitor |
509093-47-4 |
C20H21N5O4 |
|
IRAK 抑制剂 6; N-[2-甲氧基-4-(4-吗啉基)苯基]-2-(3-吡啶基)-4-噻唑甲酰 |
IRAK inhibitor 6 |
1042672-97-8 |
C20H20N4O3S |
|
IR-797氯化物 |
IR-797 chloride |
—— |
C31H34ClN2*Cl |
|
IR-780 碘化物 |
IR-780 |
207399-07-3 |
C36H44ClN2*I |
|
IR-775 氯化物 |
IR-775 chloride |
199444-11-6 |
C32H36ClN2*Cl |
|
IR-1048四氟硼酸盐 |
1-(2,6-dimethylphenyl)-3-(3-propanol)thiourea |
120077-91-0 |
C12H18N2OS |
|
IPI145中间体-5 |
8-chloro-2-phenyl-3-((1S)-1-(9-(tetrahydro-2H-pyran-2-yl)-9H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one |
1350643-73-0 |
C27H25ClN6O2 |
|
IPI-926盐酸盐 |
N-[(3R,3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethylspiro[1,2,3,4,4a,5,6,6a,6b,7,8,10,12,12a-tetradecahydronaphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridin-4-ium]-3-yl]methanesulfonamide;chloride |
1169829-40-6 |
C29H48N2O3S*ClH |
|
IPI-549,一种有效的选择性PI3KΓ抑制剂 |
IPI-549 |
1693758-51-8 |
C30H24N8O2 |
|
IPDI二乙基己酯 |
monoderm I-8 |
185568-15-4 |
C28H54N2O4 |
|
IPDI二丁基己酯 |
Carbamic acid, (3-((((isodecyloxy)carbonyl)amino)methyl)-3,5,5-trimethylcyclohexyl)-, isodecyl ester |
185568-16-5 |
C32H62N2O4 |
|